Trial Profile
Study of breast cancer prevention by letrozole in high risk women.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jun 2023
Price :
$35
*
At a glance
- Drugs Letrozole (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 02 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Apr 2015 Planned End Date changed from 1 Jul 2014 to 1 Jul 2015, according to to ClinicalTrials.gov record.
- 21 Apr 2015 Planned primary completion date changed from 1 Jul 2014 to 1 Jul 2015, according to to ClinicalTrials.gov record.